Colloid update

Area of Science:

• Critical Care Medicine
• Pharmacology
• Nephrology

Background:

• Colloids, including natural and synthetic options like hydroxyethyl starch (HES), are widely used in fluid resuscitation.
• Different generations of HES (1st, 2nd, 3rd) possess varying physicochemical properties that may influence clinical outcomes.
• Fluid resuscitation strategies, such as early goal-directed fluid therapy (EGDFT), are crucial in managing critically ill patients.

Purpose of the Study:

• To provide an evidence-based review of natural and synthetic colloids.
• To specifically evaluate the effects of different hydroxyethyl starch generations on key clinical outcomes.
• To present the evidence for colloid versus crystalloid resuscitation and discuss early goal-directed fluid therapy.

Main Methods:

• Systematic review of randomized controlled trials (RCTs) comparing colloid and crystalloid resuscitation.
• Analysis of studies investigating the impact of 1st, 2nd, and 3rd generation hetastarch on bleeding, coagulopathy, acute kidney injury, and mortality.
• Review of literature supporting the principles and application of early goal-directed fluid therapy (EGDFT).

Main Results:

• Evidence suggests varying effects of different hetastarch generations on patient outcomes, including potential risks.
• Randomized controlled trials indicate significant differences in morbidity and mortality between colloid and crystalloid resuscitation in critically ill populations.
• Dynamic measures of fluid responsiveness offer a practical approach to guide fluid therapy decisions.

Conclusions:

• The choice of colloid, particularly the generation of hydroxyethyl starch, has implications for patient safety and clinical outcomes.
• Crystalloid resuscitation may be preferred in certain critically ill patient populations due to safety concerns with specific colloids.
• Implementing EGDFT with dynamic fluid responsiveness assessment can optimize fluid management and improve patient outcomes.